首页> 外国专利> METHOD FOR PREDICTION OF MODERATELY DIFFERENTIATED ENDOMETRIOID UTERINE BODY T1N0M0 CARCINOMA COURSE IN CASE OF PRIMARY TUMOUR SIZE WITHIN 1 cm

METHOD FOR PREDICTION OF MODERATELY DIFFERENTIATED ENDOMETRIOID UTERINE BODY T1N0M0 CARCINOMA COURSE IN CASE OF PRIMARY TUMOUR SIZE WITHIN 1 cm

机译:原发性肿瘤大小在1 cm以内的中度子宫内膜异位子宫体T1N0M0癌的预测方法

摘要

FIELD: medicine.;SUBSTANCE: in case of primary tumour size within 1 cm, uterus tumour cells expressing Ki-67, 2 alpha topoisomerase are determined, 2 alpha topoisomerase/Ki-67 correlation coefficient is calculated, and at coefficient value less than or equal to 0.8, favorable outcome without adjuvant therapy is predicted. At coefficient value of more than 0.8, unfavorable course of the disease is predicted, and adjuvant therapy is recommended.;EFFECT: use of the invention allows to improve the accuracy and information content of moderately differentiated endometrioid uterine carcinomas course prediction.;1 tbl, 2 ex
机译:实体:药物:如果原发肿瘤大小在1厘米之内,则确定表达Ki-67的子宫肿瘤细胞,确定2个α拓扑异构酶,计算2个α拓扑异构酶/ Ki-67相关系数,且系数值小于或等于等于0.8,无需辅助治疗即可获得良好的预后。系数值大于0.8时,可以预测疾病的病程,并建议进行辅助治疗。效果:使用本发明可以提高中分化子宫内膜样子宫癌的病程预测的准确性和信息含量; 1 tbl, 2前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号